eflornithine has been researched along with Leukopenia in 2 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Leukopenia: A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Splinter, TA | 1 |
| Romijn, JC | 1 |
| Levin, VA | 1 |
| Chamberlain, MC | 1 |
| Prados, MD | 1 |
| Choucair, AK | 1 |
| Berger, MS | 1 |
| Silver, P | 1 |
| Seager, M | 1 |
| Gutin, PH | 1 |
| Davis, RL | 1 |
| Wilson, CB | 1 |
2 other studies available for eflornithine and Leukopenia
| Article | Year |
|---|---|
Phase I study of alpha-difluoromethylornithine and methyl-GAG.
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Deafness | 1986 |
Phase I-II study of eflornithine and mitoguazone combined in the treatment of recurrent primary brain tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Drug Eval | 1987 |